|
2,5,6-三氯苯并咪唑
|
T191441-250mg
|
≥98% |
16865-11-5 |
250mg
|
¥ 136.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,5,6-三氯苯并咪唑
|
T191441-50mg
|
≥98% |
16865-11-5 |
50mg
|
¥ 94.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-(3-(三氟甲基)苯基)哌啶-4-醇盐酸盐
|
T191438-250mg
|
≥97% |
1683-49-4 |
250mg
|
¥ 383.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-(3-(三氟甲基)苯基)哌啶-4-醇盐酸盐
|
T191438-50mg
|
≥97% |
1683-49-4 |
50mg
|
¥ 157.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-氟螺[吲哚啉-3,4'-哌啶]-1'-甲酸叔丁酯
|
T191427-250mg
|
≥96% |
167484-91-5 |
250mg
|
¥ 292.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-氟螺[吲哚啉-3,4'-哌啶]-1'-甲酸叔丁酯
|
T191427-50mg
|
≥96% |
167484-91-5 |
50mg
|
¥ 127.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-氰基-4-(吡啶-2-基)哌啶-1-羧酸叔丁酯
|
T191416-250mg
|
≥96% |
167263-04-9 |
250mg
|
¥ 829.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-氰基-4-(吡啶-2-基)哌啶-1-羧酸叔丁酯
|
T191416-50mg
|
≥96% |
167263-04-9 |
50mg
|
¥ 275.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3-羟基丁基)氨基甲酸叔丁酯
|
T191415-100mg
|
≥97% |
167216-30-0 |
100mg
|
¥ 480.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3-羟基丁基)氨基甲酸叔丁酯
|
T191415-25mg
|
≥97% |
167216-30-0 |
25mg
|
¥ 199.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4,5,6-三甲氧基-2,3-二氢-1H-茚-1-酮
|
T191414-250mg
|
≥95% |
16718-42-6 |
250mg
|
¥ 460.9
|
现货 |
|
0 |
阿拉丁 |
|
4,5,6-三甲氧基-2,3-二氢-1H-茚-1-酮
|
T191414-50mg
|
≥95% |
16718-42-6 |
50mg
|
¥ 183.9
|
现货 |
|
0 |
阿拉丁 |
|
Tert-Butyl ((3-hydroxycyclobutyl)methyl)carbamate
|
T191412-100mg
|
≥95% |
167081-41-6 |
100mg
|
¥ 179.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2-(2-(2-溴乙氧基)乙氧基)乙基)氨基甲酸叔丁酯
|
T191393-25mg
|
≥97% |
165963-71-3 |
25mg
|
¥ 44.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
6-(三氟甲基)喹唑啉-4(1H)-酮
|
T191384-100mg
|
≥97% |
16544-67-5 |
100mg
|
¥ 680.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
6-(三氟甲基)喹唑啉-4(1H)-酮
|
T191384-25mg
|
≥97% |
16544-67-5 |
25mg
|
¥ 281.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
双(噁唑-4-基甲基)氨基甲酸叔丁酯
|
T191370-100mg
|
≥97% |
1646152-48-8 |
100mg
|
¥ 129.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
双(噁唑-4-基甲基)氨基甲酸叔丁酯
|
T191370-25mg
|
≥97% |
1646152-48-8 |
25mg
|
¥ 72.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
((6-氯吡啶-2-基)甲基)氨基甲酸叔丁酯
|
T191358-250mg
|
≥97% |
1640995-60-3 |
250mg
|
¥ 189.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
((6-氯吡啶-2-基)甲基)氨基甲酸叔丁酯
|
T191358-50mg
|
≥97% |
1640995-60-3 |
50mg
|
¥ 74.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,2,2-三氟乙酸的化合物与2-(2-异丁基-6-氧代-1H-嘌呤-9(6H)-基)乙酸
|
T191354-250mg
|
≥97% |
1638487-44-1 |
250mg
|
¥ 377.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,2,2-三氟乙酸的化合物与2-(2-异丁基-6-氧代-1H-嘌呤-9(6H)-基)乙酸
|
T191354-50mg
|
≥97% |
1638487-44-1 |
50mg
|
¥ 161.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
((2-甲氧基嘧啶-4-基)甲基)氨基甲酸叔丁酯
|
T191339-100mg
|
≥95% |
1632285-98-3 |
100mg
|
¥ 171.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
((2-甲氧基嘧啶-4-基)甲基)氨基甲酸叔丁酯
|
T191339-25mg
|
≥95% |
1632285-98-3 |
25mg
|
¥ 50.9
|
期货,请咨询 |
|
0 |
阿拉丁 |